|
|
J P Iredale, R C Benyon, J Pickering, M McCullen, M Northrop, S Pawley, C Hovell, M J Arthur
J Clin Invest. 1998;
102(3):538
doi:10.1172/JCI1018
Abstract |
Full text
| PDF

L
iver fibrosis results from the excessive secretion of matrix proteins by hepatic stellate cells (HSC), which proliferate during fibrotic liver injury. We have studied a model of spontaneous recovery from liver fibrosis to determine the biological mechanisms mediating resolution. Livers were harvested from rats at 0, 3, 7, and 28 d of spontaneous recovery from liver fibrosis induced by 4 wk of twice weekly intraperitoneal injections with CCl4. Hydroxyproline analysis and histology of liver sections indicated that the advanced septal fibrosis observed at time 0 (peak fibrosis) was remodeled over 28 d of recovery to levels close to control (untreated liver). alpha-Smooth muscle actin staining of liver sections demonstrated a 12-fold reduction in the number of activated HSC over the same time period with evidence of HSC apoptosis. Ribonuclease protection analysis of liver RNA extracted at each recovery time point demonstrated a rapid decrease in expression of the collagenase inhibitors TIMP-1 and TIMP-2, whereas collagenase mRNA expression remained at levels comparable to peak fibrosis. Collagenase activity in liver homogenates increased through recovery. We suggest that apoptosis of activated HSC may vitally contribute to resolution of fibrosis by acting as a mechanism for removing the cell population responsible for both producing fibrotic neomatrix and protecting this matrix from degradation via their production of TIMPs.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(257)
| Title and authors |
Publication |
Year |
Vascular disorders
Ian R. Wanless, Weei-Yuarn Huang
|
MacSween s Pathology of the Liver
|
2012 |
Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression
Jingjing Jiao, David Sastre, Maria Isabel Fiel, Ursula E. Lee, Zahra Ghiassi-Nejad, Florent Ginhoux, Eric Vivier, Scott L. Friedman, Miriam Merad, Costica Aloman
|
Hepatology
|
2012 |
Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity : MMP expression in obesity and fatty liver
Vincent E. de Meijer, Deanna Y. Sverdlov, Hau D. Le, Yury Popov, Mark Puder
|
Hepatology Research
|
2012 |
Mechanisms of Liver Cell Destruction
Harmeet Malhi
|
Zakim and Boyer s Hepatology
|
2012 |
Hepatic Fibrosis and Cirrhosis
Don C. Rockey, Scott L. Friedman
|
Zakim and Boyer s Hepatology
|
2012 |
MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication
Yi-Xiang J Wang, Jing Yuan, Min Deng, Hing Lok Wong, Eagle S. H. Chu, Feng Zhao, Minnie Y. Y. Go, Gao-Jun Teng, Anil T. Ahuja, Jun Yu
|
Eur Radiol
|
2012 |
Combining semiquantitative measures of fibrosis and qualitative features of parenchymal remodelling to identify fibrosis regression in hepatitis C: a multiple biopsy study : HCV fibrosis regression biopsy study
Venessa Pattullo, Hla-Hla Thein, Elizabeth Jenny Heathcote, Maha Guindi
|
Histopathology
|
2012 |
Animal models for the study of hepatic fibrosis
Peter Starkel, I.A. Leclercq
|
Best Practice & Research Clinical Gastroenterology
|
2011 |
Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation
Andrew J. Fowell, Jane E. Collins, Dale R. Duncombe, Judith A. Pickering, William M.C. Rosenberg, R. Christopher Benyon
|
Biochemical and Biophysical Research Communications
|
2011 |
The use of low molecular weight heparin–pluronic nanogels to impede liver fibrosis by inhibition the TGF-β/Smad signaling pathway
Ju-Hee Lee, Hyunseung Lee, Yoon Ki Joung, Kyung Hee Jung, Jong-Hoon Choi, Don-Haeng Lee, Ki Dong Park, Soon-Sun Hong
|
Biomaterials
|
2011 |
|